We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why the Market Dipped But Tenet Healthcare (THC) Gained Today
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) ended the recent trading session at $192.85, demonstrating a +2.56% change from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.84%. Meanwhile, the Dow experienced a drop of 0.34%, and the technology-dominated Nasdaq saw a decrease of 1.43%.
Heading into today, shares of the hospital operator had lost 9.17% over the past month, lagging the Medical sector's gain of 0.16% and the S&P 500's gain of 1.8%.
Analysts and investors alike will be keeping a close eye on the performance of Tenet Healthcare in its upcoming earnings disclosure. The company's earnings report is set to go public on February 11, 2026. The company's upcoming EPS is projected at $4.05, signifying a 17.73% increase compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $5.45 billion, up 7.44% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $16.12 per share and revenue of $21.26 billion, which would represent changes of +35.69% and 0%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Tenet Healthcare. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.31% decrease. Tenet Healthcare presently features a Zacks Rank of #4 (Sell).
From a valuation perspective, Tenet Healthcare is currently exchanging hands at a Forward P/E ratio of 11.35. This signifies a premium in comparison to the average Forward P/E of 8.58 for its industry.
We can also see that THC currently has a PEG ratio of 0.8. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - Hospital industry had an average PEG ratio of 0.8 as trading concluded yesterday.
The Medical - Hospital industry is part of the Medical sector. With its current Zacks Industry Rank of 214, this industry ranks in the bottom 13% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow THC in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why the Market Dipped But Tenet Healthcare (THC) Gained Today
Tenet Healthcare (THC - Free Report) ended the recent trading session at $192.85, demonstrating a +2.56% change from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.84%. Meanwhile, the Dow experienced a drop of 0.34%, and the technology-dominated Nasdaq saw a decrease of 1.43%.
Heading into today, shares of the hospital operator had lost 9.17% over the past month, lagging the Medical sector's gain of 0.16% and the S&P 500's gain of 1.8%.
Analysts and investors alike will be keeping a close eye on the performance of Tenet Healthcare in its upcoming earnings disclosure. The company's earnings report is set to go public on February 11, 2026. The company's upcoming EPS is projected at $4.05, signifying a 17.73% increase compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $5.45 billion, up 7.44% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $16.12 per share and revenue of $21.26 billion, which would represent changes of +35.69% and 0%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Tenet Healthcare. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.31% decrease. Tenet Healthcare presently features a Zacks Rank of #4 (Sell).
From a valuation perspective, Tenet Healthcare is currently exchanging hands at a Forward P/E ratio of 11.35. This signifies a premium in comparison to the average Forward P/E of 8.58 for its industry.
We can also see that THC currently has a PEG ratio of 0.8. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - Hospital industry had an average PEG ratio of 0.8 as trading concluded yesterday.
The Medical - Hospital industry is part of the Medical sector. With its current Zacks Industry Rank of 214, this industry ranks in the bottom 13% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow THC in the coming trading sessions, be sure to utilize Zacks.com.